Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2028

Conditions
Breast Cancer
Interventions
DRUG

Huaier granule

On the basis of routine clinical treatment/follow-up, take Huaier Granules orally, 10g each time, three times a day, for one year continuously or until disease progression, intolerable toxicity, withdrawal from the study for any reason or death occurs, whichever occurs first.

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

collaborator

Huazhong University of Science and Technology

OTHER

lead

Fudan University

OTHER